Koyfin Home > Directory > Health Care > Adamas Pharma > EV / Sales (ltm)

Adamas Pharma EV / Sales (ltm) Chart (ADMS)

Adamas Pharma annual/quarterly EV / Sales (ltm) from 2014 to 2020.
  • Adamas Pharma EV / Sales (ltm) for the quarter ending September 09, 2020 was 2.64 a 2.52% increase of 0.07 year over year
  • Adamas Pharma EV / Sales (ltm) for the last 12 months ending September 09, 2020 was 2.64 a 2.52% increase of 0.07 year over year
  • Adamas Pharma Annual EV / Sales (ltm) for 2020 was 2.64 a 0.50% increase of 0.01 from 2019
  • Adamas Pharma Annual EV / Sales (ltm) for 2020 was 2.63 a -0.51% decrease of -0.01 from 2019
  • Adamas Pharma Annual EV / Sales (ltm) for 2020 was 2.64 a 2.52% increase of 0.07 from 2019
Other Valuation Metrics:
  • Adamas Pharma Market Cap for the quarter ending March 03, 2018 was $641m a 38.96% increase of 250m year over year
  • Adamas Pharma Price / Book for the quarter ending March 03, 2018 was 8.43 a 61.32% increase of 5.17 year over year
  • Adamas Pharma Enterprise Value for the quarter ending March 03, 2018 was $570m a 51.05% increase of 291m year over year
View Chart On Koyfin

Quarterly ADMS EV / Sales (ltm) Data

09/20202.64
09/20202.63
09/20202.64
09/20202.58
09/20202.50
09/20202.44
09/20202.46
09/20202.44
09/20202.78
09/20202.85

Annual ADMS EV / Sales (ltm) Data

20202.64
20202.63
20202.64
20202.58
20202.50
20202.44
20202.46
20202.44
20202.78
20202.85